CDC announces shorter quarantine options for people exposed to COVID-19 virus

Dec 02, 2020 - 04:08 PM
cdc-update

The Centers for Disease Control and Prevention today announced shorter quarantine options based on local circumstances and resources, for people exposed to the COVID-19 virus. Under the new options, individuals exposed to the COVID-19 virus may end the recommended 14-day quarantine after 10 days if they reported no symptoms during daily monitoring and after seven days if they reported no symptoms and a diagnostic specimen test in the prior 48 hours was negative. In both cases, the individuals should continue symptom monitoring and masking through Day 14, among other actions.

The agency today said it continues to recommend postponing domestic travel and international air travel to protect yourself and others during the pandemic. For those who decide to travel, the agency recommends viral testing 1-3 days before and 3-5 days after travel.

Individuals should stay home for seven days after travel if they test negative, and for 10 days after travel if they don’t get tested, the agency said.

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…